Contract V797D6002E
Vyera Pharmaceuticals, Llc · Department Of Veterans Affairs · October 16, 2015
Vyera Pharmaceuticals, Llc was awarded a federal contract by Department Of Veterans Affairs on October 16, 2015 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 15, 2016. If all options are exercised, the contract could reach $25,000.
Contract details
- PIID
- V797D6002E
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- October 16, 2015
- Latest action
- September 15, 2016
Description
65IB - CONTRACT CANCELLATION
Modification timeline
-
September 15, 2016Mod P00007$0
-
July 26, 2016Mod P0000665IB - PRODUCT ADDITION/NEW PACKAGE SIZE$0
-
April 13, 2016Mod P00003INTERIM AGREEMENT V797D-6002E FOR COMPLIANCE WITH PL 102-585 / TEMPORARY CONTRACT EXTENSION THROUGH 6/14/2016.$0
-
October 16, 2015Base awardINTERIM AGREEMENT V797D-6002E FOR COMPLIANCE WITH PL 102-585$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D6002E?
Contract V797D6002E is a federal contract awarded to Vyera Pharmaceuticals, Llc by Department Of Veterans Affairs on October 16, 2015 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract V797D6002E?
Vyera Pharmaceuticals, Llc won contract V797D6002E from Department Of Veterans Affairs.
How much is contract V797D6002E worth?
Contract V797D6002E has obligated $0 to date but carries a potential ceiling of $25,000 if fully funded and all options are exercised.